SPDR S&P Biotech ETF $XBI Stock Holdings Increased by AlphaCore Capital LLC

AlphaCore Capital LLC raised its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1,638.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 7,650 shares of the exchange traded fund’s stock after purchasing an additional 7,210 shares during the quarter. AlphaCore Capital LLC’s holdings in SPDR S&P Biotech ETF were worth $933,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the company. JPMorgan Chase & Co. raised its position in shares of SPDR S&P Biotech ETF by 27.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock valued at $1,356,582,000 after acquiring an additional 2,900,633 shares in the last quarter. Bessemer Group Inc. increased its stake in SPDR S&P Biotech ETF by 13.5% during the fourth quarter. Bessemer Group Inc. now owns 1,853,232 shares of the exchange traded fund’s stock valued at $225,965,000 after purchasing an additional 220,244 shares during the last quarter. Ameriprise Financial Inc. increased its stake in SPDR S&P Biotech ETF by 40.5% during the third quarter. Ameriprise Financial Inc. now owns 1,226,147 shares of the exchange traded fund’s stock valued at $122,906,000 after purchasing an additional 353,351 shares during the last quarter. Greenhouse Funds LLLP raised its holdings in shares of SPDR S&P Biotech ETF by 16.6% during the third quarter. Greenhouse Funds LLLP now owns 675,975 shares of the exchange traded fund’s stock worth $67,733,000 after purchasing an additional 96,308 shares during the period. Finally, Assetmark Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 1,042,265.6% during the fourth quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock worth $77,528,000 after purchasing an additional 635,782 shares during the period.

SPDR S&P Biotech ETF Stock Down 2.3%

Shares of NYSEARCA:XBI opened at $127.67 on Tuesday. The company has a market cap of $8.15 billion, a PE ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a fifty-two week low of $78.00 and a fifty-two week high of $139.19. The firm has a 50-day simple moving average of $129.46 and a 200 day simple moving average of $124.61.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.